Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular
Shishuai Meng1, Kai Kang1, Dongsheng Fei1
1Department of Intensive Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Background:
Sepsis typically results in enhanced coagulation system activation and microthrombus formation. Microparticle (MP) production promotes coagulation and enhances pro-coagulation. This study investigated how circulating MP levels and tissue factor-bearing MP (TF+-MP) activity caused coagulation in patients with septic disseminated intravascular coagulation (DIC).
Methods:
Thirty patients with septic DIC and 30 healthy controls were studied from December 2017 to March 2019. Patient blood samples were collected at enrolment (day 1) and on days 3 and 5; DIC scores and Sequential Organ Failure Assessment (SOFA) scores were recorded. TF+-MP activity was measured using TF-dependent factor Xa generation experiments. Circulating MP concentrations were determined by MP capture assay. Clotting factor activity, antithrombin level, soluble thrombomodulin, and serum tissue factor pathway inhibitor (TFPI) concentrations were measured.
Results:
Patients with septic DIC had lower circulating MP levels than healthy control patients. Circulating MP levels in patients with septic DIC were positively correlated with DIC scores and negatively correlated with coagulation factors, but TF+-MP activity did not correlate with clotting factor levels and TFPI.
Conclusions:
In patients with septic DIC, circulating MP levels are important in promoting coagulation activation and increasing clotting factor consumption. TF+-MP activity may not be the main form of active TF.
Insights
In sepsis with disseminated intravascular coagulation (DIC), lower circulating microparticle (MP) levels correlate with clotting factor consumption. Tissue factor-bearing MP (TF+-MP) activity may not be the primary driver of coagulation in these patients.
Area of Science:
- Hematology
- Critical Care Medicine
- Pathophysiology
Background:
- Sepsis frequently triggers hypercoagulation and microthrombus formation.
- Microparticles (MPs) are known to promote coagulation and pro-coagulant activity.
- Investigating the role of MPs and tissue factor-bearing MPs (TF+-MPs) in septic disseminated intravascular coagulation (DIC) is crucial.
Purpose of the Study:
- To determine the relationship between circulating MP levels, TF+-MP activity, and coagulation status in patients with septic DIC.
- To compare MP levels and TF+-MP activity between septic DIC patients and healthy controls.
Main Methods:
- Studied 30 patients with septic DIC and 30 healthy controls.
- Measured circulating MP concentrations, TF+-MP activity (via factor Xa generation), clotting factor activity, antithrombin, soluble thrombomodulin, and serum tissue factor pathway inhibitor (TFPI).
- Collected blood samples at multiple time points and recorded DIC and SOFA scores.
Main Results:
- Patients with septic DIC exhibited lower circulating MP levels compared to healthy controls.
- Circulating MP levels positively correlated with DIC scores and negatively with coagulation factors.
- TF+-MP activity did not show a correlation with clotting factor levels or TFPI.
Conclusions:
- Circulating MP levels play a significant role in coagulation activation and clotting factor consumption in septic DIC.
- TF+-MP activity might not represent the predominant form of active tissue factor in septic DIC.
- Further research is needed to elucidate the precise mechanisms of MP involvement in septic coagulopathy.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016